Roa 11a-Hydroxy canneone methacrylate Malosiaga HPLC ma98% | AASraw
AASraw gaosia Cannabidiol (CBD) paʻu ma Hemp Taua Suauʻu tele!

11a-Hydroxy Canrenone Methacrylate Powder (192704-56-6)

fua faatatau: SKU: 192704-56-6. Category:

AASraw o loʻo i ai le faʻasologa ma le gaosiga gafatia mai le gram i le faʻatonuga tele o le 11a-Hydroxy Canrenone Methacrylate Powder (192704-56-6), i lalo o tulafono a le CGMP ma le faʻatonutonuina o le lelei o le faʻaleleia o le tino.

AASRAW paʻu PDF Icon

Faamatalaga oloa

 

11a-Hydroxy Canrenone Methacrylate Powder (192704-56-6) vitio

 

 


 

11a-Hydroxy Caneneone Methacrylate Powder (192704-56-6) Specification:

Faʻatulagaga Faʻamatalaga: Igoa oloa:11a-Hydroxy canrenone methacrylate
Roa 11a-Hydroxy canneone methacrylate Malosiaga HPLC ma98% | AASraw Cas No.: 192704-56-6
Faiga Faʻavae Molecular: C24H32O6
Taumaʻa Masele: 416.50728
Fa'amatalaga: 11-a-Hydroxy canrenone methyl ester
Teuina o meaai: Faʻamago, pogisa · ma ile 0 - 4 C mo se taimi puʻupuʻu (aso i vaiaso) poʻo le -20 C mo se taimi umi (masina i tausaga).
Pepa aloaia (COA & HPLC ma isi): iai

11a-Hydroxy Caneneone Methacrylate Powder (192704-56-6) Digoa:

11α-Hydroxy canrenone methacrylate galue tutusa ma Canrenone o se ald testosterone antagonist ma le potassium-faasaoina diuretic gaioiga. Canrenone faʻapitoa antagonizes aldostero i le mineralocorticoid receptor i totonu o fatugaʻo, ma faʻateleina sodium excretion ma taofia ai le faʻasaina o le potassium. Canrenone ua lipotia sili atu le malosi o se antimineralocorticoid fesoʻotaʻi ma spironolactone, ae e matua tele lava le malosi ma aoga o se antiandrogen.11α-Hydroxyprogesterone o se endogenous steroid and metabolite of progesterone. O se antiandrogen vaivai, ma e leai se androgenia, estrogenic, ma progestogenic gaioiga

methacrylate o se monomer masani mo le sauniuniga o le polymerite o le acrylate. O le methacrylate e masani lava ona polymerized i lalo o fualaau faasaina saoloto.

 

Tusitaiala o le:

  • Jürg Müller (6 Tesema 2012). Faʻatonutonuina o le Aldolone Biosynthesis: Physiological and Clinical Aspects. Springer Saienisi & Pisinisi Ala o Faʻasalalauga. i. 164–. ISBN 978-3-642-83120-1.
  • Ford, Donald H. (1954). "Aafiaga o le 11α-HYDROXYPROGESTERONE I LE FAʻAFAIGALUEGA SITUSI O LE TUPULAGA MA FANAU AʻOAʻOGA AUTELE FUA *". Le Tusi Faʻafomaʻi o le Clinical Endocrinology & Metabolism. 14 (10): 1268–1270. faia: 10.1210 / jcem-14-10-1268. ISSN 0021-972X.
  • Souness GW, Latif SA, Laurenzo JL, Morris DJ (1995). "11 alpha- ma 11 beta-hydroxyprogesterone, malosi taofiofia o 11 beta-hydroxysteroid dehydrogenase (isoforms 1 ma 2), faʻaee faʻailogaina mineralocorticoid gaioiga i luga o le corticostero i le ADX rat". Endocrinology. 136 (4): 1809–12.